Euodiae Fructus: a review of botany, application, processing, phytochemistry, quality control, pharmacology, and toxicology
Yule Hao,
No information about this author
Jiawen Qi,
No information about this author
Xinggui Huang
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 29, 2025
Euodiae
Fructus
(EF)
is
the
dried
and
nearly
ripe
fruit
of
Euodia
rutaecarpa
,
first
recorded
in
Shen
Nong’s
Herbal
Classic
.
EF
a
versatile
Traditional
Chinese
Medicine
(TCM)
known
for
effects
dispelling
colds
alleviating
pain,
suppressing
adverse
qi
to
relieve
vomiting,
boosting
yang
mitigate
diarrhea.
However,
it
should
be
noted
that
possesses
mild
toxicity.
In
TCM
prescriptions,
employed
treat
various
ailments,
including
abdominal
diarrhea,
chronic
non-atrophic
gastritis,
irritable
bowel
syndrome,
primary
dysmenorrhea.
This
review
collected
literature
published
before
September
2024
on
EF.
An
exhaustive
analysis
was
conducted
utilizing
multiple
sources,
namely
classic
books
scientific
databases
like
Web
Science,
PubMed,
Elsevier,
ACS,
ResearchGate,
Google
Scholar,
National
Knowledge
Infrastructure.
So
far,
more
than
300
metabolites
have
been
extracted
identified
from
EF,
exhibiting
pharmacological
effects,
such
as
cardiovascular
protection,
gastrointestinal
neuroprotection,
anti-inflammation,
analgesia,
anti-tumor,
glucose
lipid
metabolism
regulation,
etc.
It
also
exhibits
diverse
toxicological
properties
poses
specific
toxic
risks
liver,
heart,
kidney.
Nonetheless,
research
scarce
regarding
toxicology
especially
its
cardiotoxicity
nephrotoxicity.
Further
in-depth
necessary
explore
mechanisms
underlying
EF’s
develop
strategies
quality
control
toxicity
mitigation.
The
can
reduced
by
processing,
but
this
aspect
rarely
discussed,
needs
further
standardized.
Evodiamine,
rutaecarpine,
limonin
are
effective
one
causes
evodiamine
rutaecarpine
intensely
studied,
there
few
studies
other
Therefore,
paper
focuses
botanical
characteristics,
traditional
applications,
processing
methods,
phytochemistry,
control,
pharmacology,
We
hope
provides
theoretical
basis
future
high-value
high-connotation
development
Language: Английский
Network Pharmacology and Experimental Validation Reveal Sishen Pill’s Efficacy in Treating NSAID-Induced Small Intestinal Ulcers
Jiangtao Zhou,
No information about this author
Fengting Zhu,
No information about this author
Hong Liang
No information about this author
et al.
Drug Design Development and Therapy,
Journal Year:
2025,
Volume and Issue:
Volume 19, P. 2035 - 2050
Published: March 1, 2025
Nonsteroidal
anti-inflammatory
drugs
(NSAIDs)
are
widely
used
but
often
cause
small
intestinal
ulcers
(SIUs),
for
which
effective
therapies
lacking.
Sishen
Pill
(SSP),
a
traditional
Chinese
medicine,
shows
therapeutic
promise,
yet
its
mechanisms
remain
unclear.
This
study
integrates
network
pharmacology,
molecular
docking,
and
experimental
validation
to
systematically
investigate
SSP's
protective
against
NSAID-induced
SIUs.
Active
SSP
ingredients
were
screened
using
the
Traditional
Medicine
Systems
Pharmacology
(TCMSP)
Encyclopedia
of
(ETCM)
databases.
SIU-related
targets
retrieved
from
GeneCards
DisGeNET.
Protein-protein
interaction
(PPI)
networks
constructed
via
STRING
Cytoscape,
followed
by
Gene
Ontology
(GO)
Kyoto
Genes
Genomes
(KEGG)
pathway
enrichment
analyses.
Molecular
docking
(AutoDock
Vina,
PyMOL)
validated
ligand-target
interactions.
In
vivo
employed
an
indomethacin-induced
SIU
rat
model
assess
effects
on
ulcer
severity,
inflammation,
oxidative
stress,
PI3K/AKT
signaling.
We
identified
66
bioactive
ingredients,
222
drug
targets,
144
targets.
revealed
high
binding
affinity
components
(quercetin,
bavachinin,
rutaecarpine,
evodiamine)
key
(AKT1,
HSP90AA1,
IL6,
MAPK1,
BCL2).
KEGG
analysis
highlighted
as
central.
vivo,
reduced
indices,
suppressed
pro-inflammatory
cytokines
(TNF-α,
IL-1β,
IL-6),
attenuated
stress.
also
downregulated
PI3K
AKT1
mRNA
expression,
confirming
modulation.
elucidates
multi-target
mechanism
SIUs,
emphasizing
role
in
suppressing
These
findings
provide
scientific
foundation
clinical
application
highlight
potential
safe,
alternative
conventional
therapies.
Language: Английский
ATF3 Restoration as a Potential Strategy in Managing Ulcerative Colitis: Implications from Sishen Pill Research
Yutong Jin,
No information about this author
Xuetao Dong,
No information about this author
Weilong Zhong
No information about this author
et al.
Phytomedicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 156814 - 156814
Published: April 1, 2025
Language: Английский
Sishen Pills Inhibit Inflammatory Dendritic Cell Differentiation via miR-505-3p mediated E-cadherin Downregulation in Ulcerative Colitis
Phytomedicine,
Journal Year:
2024,
Volume and Issue:
135, P. 156035 - 156035
Published: Sept. 19, 2024
Language: Английский
Integrating UPLC-Q-Exactive Orbitrap/MS, Network pharmacology and experimental validation to reveal the potential mechanism of Kadsura cocicinea roots in Colon Cancer
Journal of Ethnopharmacology,
Journal Year:
2024,
Volume and Issue:
337, P. 118934 - 118934
Published: Oct. 12, 2024
Language: Английский
Traditional Chinese Medicine Formulas-Based Interventions on Colorectal Carcinoma Prevention: The Efficacies, Mechanisms and Advantages
Xiaojuan Tang,
No information about this author
He Min,
No information about this author
Yuan Ren
No information about this author
et al.
Journal of Ethnopharmacology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 119008 - 119008
Published: Oct. 1, 2024
Language: Английский
Ultra‐High Performance Liquid Chromatography/Triple Quadrupole Ion‐Trap Mass Spectrometry‐Based Quantitative Assay of 17 Compounds to Unveil the Extraction Difference of Potentially Toxic Components Between the Single Drugs and Sishen Formula
M Wang,
No information about this author
Wandi Hu,
No information about this author
Jia Lou
No information about this author
et al.
Separation Science Plus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 2, 2024
ABSTRACT
Sishen
formula
is
a
famous
prescription
utilized
to
treat
kidney
diarrhea.
The
main
components
of
Psoraleae
Fructus
and
Euodiae
are
reported
with
the
liver
toxicity;
however,
dissolution
difference
those
toxic
compounds
among
single
medicine
decoctions
versatile
compatibility
forms
has
yet
not
been
documented
by
quantitative
assays.
We
established
validated
an
ultra‐high
performance
liquid
chromatography/triple
quadrupole‐linear
ion‐trap
mass
spectrometry‐multiple
reaction
monitoring
approach
targeting
17
(e.g.,
four
coumarins
eight
flavonoids
from
Fructus;
three
alkaloids
two
limonoids
Fructus).
Co‐decoction
Myristicae
Semen
or
Schisandrae
Chinensis
could
significantly
affect
Fructus,
whereas
weak
influence
was
observed
for
combining
Fructus.
Combination
increase
contents
both
but
effect
relatively
slight.
Moreover,
in
remarkably
inhibited,
compared
pure
decoction,
variation
between
decoction
formula.
These
results
benefit
bridge
efficacy
toxicity
changes
Language: Английский